BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 27416313)

  • 1. Isotretinoin for acne and rosacea.
    Watson KD; Miest RY; Tollefson MM
    Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's new in acne and rosacea?
    Keri J
    Semin Cutan Med Surg; 2016 Jun; 35(2):103-6. PubMed ID: 27416316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?
    Rademaker M
    Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin: controversies, facts, and recommendations.
    Bauer LB; Ornelas JN; Elston DM; Alikhan A
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.
    Rigopoulos D; Larios G; Katsambas AD
    Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Layton AM; Dréno B; Gollnick H; Mobaken H; Shear N
    Br J Dermatol; 2009 Jan; 160(1):217-8; author reply 218-9. PubMed ID: 19067687
    [No Abstract]   [Full Text] [Related]  

  • 8. On isotretinoin dosing, adverse effects, and efficacy.
    Berk DR
    Australas J Dermatol; 2011 May; 52(2):147-8; author reply 148. PubMed ID: 21605103
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of extrafacial rosacea with low-dose isotretinoin.
    Bostanci O; Borelli C; Schaller M
    Acta Derm Venereol; 2010 Jul; 90(4):409-10. PubMed ID: 20574608
    [No Abstract]   [Full Text] [Related]  

  • 12. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
    Verros CD; Rallis E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
    Boyraz N; Mustak PK
    Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatological indications for the use of isotretinoin beyond acne.
    Forbat E; Ali FR; Al-Niaimi F
    J Dermatolog Treat; 2018 Nov; 29(7):698-705. PubMed ID: 29480033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients.
    Rademaker M
    Australas J Dermatol; 2018 Feb; 59(1):26-30. PubMed ID: 27435665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. We Pledge to Change iPLEDGE.
    Pierson JC; Ferris LK; Schwarz EB
    JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
    [No Abstract]   [Full Text] [Related]  

  • 19. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.
    Azoulay L; Oraichi D; Bérard A
    Br J Dermatol; 2007 Dec; 157(6):1240-8. PubMed ID: 17970803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose isotretinoin in the treatment of acne vulgaris.
    Amichai B; Shemer A; Grunwald MH
    J Am Acad Dermatol; 2006 Apr; 54(4):644-6. PubMed ID: 16546586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.